Publication Name	World Journal of Gastrointestinal Pathophysiology
Manuscript ID	28124
Country	Iran

Received	2016-06-27 10:09
Peer-Review Started	2016-06-29 08:36
To Make the First Decision	2016-08-04 16:11
Return for Revision	2016-08-05 09:57
Revised	2016-08-30 12:02
Second Decision	2017-01-22 16:42
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2017-02-13 13:34
Articles in Press	2017-02-13 13:34
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2017-05-13 17:55
Publish the Manuscript Online	2017-05-16 06:56

ISSN	2150-5330 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Diagnostic Advances
Article Title	Nonalcoholic fatty liver disease: Diagnostic biomarkers
Manuscript Source	Invited Manuscript
All Author List	Fatemeh Hadizadeh, Elham Faghihimani and Peyman Adibi
Funding Agency and Grant Number
Corresponding Author	Elham Faghihimani, MD, Gastroen­terology Research Center, Isfahan University of Medical Sciences, Hezar Jarib Blvd., Isfahan 81746 73461, Iran. efimani@yahoo.com
Key Words	Nonalcoholic fatty liver disease; Non-alcoholic steatohepatitis; Liver fibrosis; Cirrhosis
Core Tip	Nonalcoholic fatty liver disease is a pandemic disease in both developed and developing countries. There is emerging scientific evidence in this field that needs to be classified and summarized to make conceptual maps for researchers as well as practitioners. This article aimed to cover diagnostic markers in this disease, considering limitations and applications.
Publish Date	2017-05-16 06:56
Citation	Hadizadeh F, Faghihimani E, Adibi P. Nonalcoholic fatty liver disease: Diagnostic biomarkers. World J Gastrointest Pathophysiol 2017; 8(2): 11-26
URL	http://www.wjgnet.com/2150-5330/full/v8/i2/11.htm
DOI	http://dx.doi.org/10.4291/wjgp.v8.i2.11

Full Article (PDF)	WJGP-8-11.pdf
Full Article (Word)	WJGP-8-11.doc
Manuscript File	28124-Review.docx
Answering Reviewers	28124-Answering reviewers.pdf
Audio Core Tip	28124-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	28124-Conflict-of-interest statement.pdf
Copyright License Agreement	28124-Copyright assignment.pdf
Peer-review Report	28124-Peer-review(s).pdf
Scientific Misconduct Check	28124-Scientific misconduct check.pdf
Scientific Editor Work List	28124-Scientific editor work list.pdf